Exploring new worlds: the epigenetic contributors to multiple myeloma
Felipe Prosper Cardoso
Biosimilar benefits: cost saving in the NHS
The joint symposium run by EHA and ESH
Targeting DNA methylation as a therapeutic target in multiple myeloma
How can we assess quality of life in AML patients?